Quick Takeaways
- Carlyle Group Inc. filed SCHEDULE 13D/A for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR).
- Disclosed ownership: 3.8%.
- Date of event: 18 Feb 2026.
Carlyle Group Inc. - 18 Feb 2026 SCHEDULE 13D/A Report for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR)
- Filing Manager
- Carlyle Group Inc.
- Reporting Manager
- The Carlyle Group Inc.
- Symbol
- JSPR
- Shares outstanding
- 28,639,737 shares
- Disclosed Ownership
- 1,088,310 shares
- Ownership
- 3.8%
- Form type
- SCHEDULE 13D/A
- Filing time
- 18 Feb 2026, 17:29:20 UTC
- Date of event
- 18 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Carlyle Group Inc. disclosed 3.8% ownership in Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR) on 18 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Feb 2026, 17:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (10)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Carlyle Group Inc. | 3.8% | 1,088,310 | 0 | 1,088,310 | /s/ Anne K. Frederick | Anne K. Frederick, Corporate Secretary | 0001527166 |
| Carlyle Holdings I GP Inc. | 3.8% | 1,088,310 | 0 | 1,088,310 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001548626 |
| Carlyle Holdings I GP Sub L.L.C. | 3.8% | 1,088,310 | 0 | 1,088,310 | By: Carlyle Holdings I GP Inc., its sole member, /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001548627 |
| Carlyle Holdings I L.P. | 3.8% | 1,088,310 | 0 | 1,088,310 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001548628 |
| CG Subsidiary Holdings L.L.C. | 3.8% | 1,088,310 | 0 | 1,088,310 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001790577 |
| TC Group, L.L.C. | 3.8% | 1,088,310 | 0 | 1,088,310 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0000933790 |
| Carlyle Investment Management L.L.C. | 3.8% | 1,088,310 | 0 | 1,088,310 | /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001354120 |
| Carlyle Genesis UK LLC | 3.8% | 1,088,310 | 0 | 1,088,310 | By: Carlyle Investment Management L.L.C., its sole member, /s/ Anne K. Frederick | Anne K. Frederick, Managing Director | 0001941860 |
| Abingworth LLP | 3.8% | 1,088,310 | 0 | 1,088,310 | /s/ Emma O'Reilly | Emma O'Reilly, Authorized Signatory | 0001397144 |
| Abingworth Bioventures VII LP | 3.8% | 1,088,310 | 0 | 1,088,310 | /s/ Emma O'Reilly | Emma O'Reilly, Authorized Signatory | 0001688313 |